The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
J R Soc Med. 2021 Mar;114(3):121-131. doi: 10.1177/0141076821992453. Epub 2021 Feb 9.
We examined if the WHO International Health Regulations (IHR) capacities were associated with better COVID-19 pandemic control.
Observational study.
Population-based study of 114 countries.
General population.
For each country, we extracted: (1) the maximum rate of COVID-19 incidence increase per 100,000 population over any 5-day moving average period since the first 100 confirmed cases; (2) the maximum 14-day cumulative incidence rate since the first case; (3) the incidence and mortality within 30 days since the first case and first COVID-19-related death, respectively. We retrieved the 13 country-specific International Health Regulations capacities and constructed linear regression models to examine whether these capacities were associated with COVID-19 incidence and mortality, controlling for the Human Development Index, Gross Domestic Product, the population density, the Global Health Security index, prior exposure to SARS/MERS and Stringency Index.
Countries with higher International Health Regulations score were significantly more likely to have lower incidence (β coefficient -24, 95% CI -35 to -13) and mortality (β coefficient -1.7, 95% CI -2.5 to -1.0) per 100,000 population within 30 days since the first COVID-19 diagnosis. A similar association was found for the other incidence outcomes. Analysis using different regression models controlling for various confounders showed a similarly significant association.
The International Health Regulations score was significantly associated with reduction in rate of incidence and mortality of COVID-19. These findings inform design of pandemic control strategies, and validated the International Health Regulations capacities as important metrics for countries that warrant evaluation and improvement of their health security capabilities.
我们研究了世界卫生组织(WHO)《国际卫生条例》(IHR)能力是否与更好地控制 COVID-19 大流行有关。
观察性研究。
对 114 个国家进行基于人群的研究。
普通人群。
对于每个国家,我们提取了以下数据:(1)自首例确诊病例以来的任何 5 天移动平均期间内,每 10 万人 COVID-19 发病率增加的最大值;(2)首例病例以来的 14 天累积发病率最大值;(3)首例病例和首例与 COVID-19 相关死亡病例后 30 天内的发病率和死亡率。我们检索了 13 项国家特定的《国际卫生条例》能力,并构建了线性回归模型,以检验这些能力与 COVID-19 的发病率和死亡率是否相关,同时控制了人类发展指数、国内生产总值、人口密度、全球卫生安全指数、先前 SARS/MERS 暴露情况和严格指数。
《国际卫生条例》评分较高的国家,在首例 COVID-19 诊断后 30 天内,每 10 万人的发病率(β系数-24,95%CI-35 至-13)和死亡率(β系数-1.7,95%CI-2.5 至-1.0)显著较低。其他发病率结果也发现了类似的关联。使用不同回归模型控制各种混杂因素进行分析,结果也显示出相似的显著关联。
《国际卫生条例》评分与 COVID-19 发病率和死亡率的降低显著相关。这些发现为大流行控制策略的设计提供了信息,并验证了《国际卫生条例》能力作为评估和改进卫生安全能力的重要指标,对各国具有重要意义。